摘要

Objective: To explore the efficacy of Lianhua Qingwen Capsule(莲花清瘟胶囊) on upper respiratory tract infection, to understand the impact of Lianhua Qingwen Capsule(莲花清瘟胶囊) on the treatment outcome of upper respiratory tract infection, and provide reference for rational clinical drug use. Methods: The HIS database based on 18 large third-grade class-A hospitals was selected to match 1:1 for upper respiratory tract infection patients using and without Lianhua Qingwen Capsule(莲花清瘟胶囊) according to certain standards. The recombination of treatment outcome as "recovery" and "improvement" in the database was defined as effective treatment, "ineffectiveness", "death" and "other" as ineffectivetreatment populations, and the effectiveness of treatment outcomes in the remerged 2 groups was compared by propensity score method. Results: After matching, 454 cases were in both the patients treated by(experimental group) and without(control group) Lianhua Qingwen Capsule(莲花清瘟胶囊). Analysis was performed by three Logistic regression methods, all showing regression coefficients greater than 0 and statistically significant differences(P<0.05). Conclusion: Patients with upper respiratory tract infection treated by Lianhua Qingwen Capsule(莲花清瘟胶囊) are more effective than that without Lianhua Qingwen Capsule(莲花清瘟胶囊), it can improve the clinical efficacy of patients with upper respiratory tract infection

  • 单位
    中医学科学院